131 related articles for article (PubMed ID: 9075809)
1. Hypertension as a risk factor for diabetic neuropathy: a prospective study.
Forrest KY; Maser RE; Pambianco G; Becker DJ; Orchard TJ
Diabetes; 1997 Apr; 46(4):665-70. PubMed ID: 9075809
[TBL] [Abstract][Full Text] [Related]
2. Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study.
Orchard TJ; LLoyd CE; Maser RE; Kuller LH
Diabetes Res Clin Pract; 1996 Oct; 34 Suppl():S165-71. PubMed ID: 9015687
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for progression of distal symmetric polyneuropathy in type 1 diabetes mellitus. Sorbinil Retinopathy Trial Research Group.
Christen WG; Manson JE; Bubes V; Glynn RJ
Am J Epidemiol; 1999 Dec; 150(11):1142-51. PubMed ID: 10588075
[TBL] [Abstract][Full Text] [Related]
4. Incidence of complications in insulin-dependent diabetes mellitus: a survival analysis.
Lloyd CE; Becker D; Ellis D; Orchard TJ
Am J Epidemiol; 1996 Mar; 143(5):431-41. PubMed ID: 8610658
[TBL] [Abstract][Full Text] [Related]
5. The assessment of clinical distal symmetric polyneuropathy in type 1 diabetes: a comparison of methodologies from the Pittsburgh Epidemiology of Diabetes Complications Cohort.
Pambianco G; Costacou T; Strotmeyer E; Orchard TJ
Diabetes Res Clin Pract; 2011 May; 92(2):280-7. PubMed ID: 21411172
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus.
Witte DR; Tesfaye S; Chaturvedi N; Eaton SE; Kempler P; Fuller JH;
Diabetologia; 2005 Jan; 48(1):164-71. PubMed ID: 15619072
[TBL] [Abstract][Full Text] [Related]
7. Heart rate variability and sensorimotor polyneuropathy in type 1 diabetes.
Orlov S; Bril V; Orszag A; Perkins BA
Diabetes Care; 2012 Apr; 35(4):809-16. PubMed ID: 22357183
[TBL] [Abstract][Full Text] [Related]
8. Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
Diabetes; 1988 Apr; 37(4):476-81. PubMed ID: 2897940
[TBL] [Abstract][Full Text] [Related]
9. The prevalence, clinical features and management of periphral neuropathy among diabetic patients in Tikur Anbessa and St. Paul's Specialized University Hospitals, Addis Ababa, Ethiopia.
Jarso G; Ahmed A; Feleke Y
Ethiop Med J; 2011 Oct; 49(4):299-311. PubMed ID: 23409395
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
[TBL] [Abstract][Full Text] [Related]
11. Coronary artery disease in IDDM. Gender differences in risk factors but not risk.
Lloyd CE; Kuller LH; Ellis D; Becker DJ; Wing RR; Orchard TJ
Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):720-6. PubMed ID: 8640398
[TBL] [Abstract][Full Text] [Related]
12. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study.
Dyck PJ; Kratz KM; Karnes JL; Litchy WJ; Klein R; Pach JM; Wilson DM; O'Brien PC; Melton LJ; Service FJ
Neurology; 1993 Apr; 43(4):817-24. PubMed ID: 8469345
[TBL] [Abstract][Full Text] [Related]
13. Glycemic control is related to the morphological severity of diabetic sensorimotor polyneuropathy.
Perkins BA; Greene DA; Bril V
Diabetes Care; 2001 Apr; 24(4):748-52. PubMed ID: 11315842
[TBL] [Abstract][Full Text] [Related]
14. Vascular risk factors and diabetic neuropathy.
Tesfaye S; Chaturvedi N; Eaton SE; Ward JD; Manes C; Ionescu-Tirgoviste C; Witte DR; Fuller JH;
N Engl J Med; 2005 Jan; 352(4):341-50. PubMed ID: 15673800
[TBL] [Abstract][Full Text] [Related]
15. Glycemic control is related to the electrophysiologic severity of diabetic peripheral sensorimotor polyneuropathy.
Tkac I; Bril V
Diabetes Care; 1998 Oct; 21(10):1749-52. PubMed ID: 9773742
[TBL] [Abstract][Full Text] [Related]
16. Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus. The glycemic threshold revisited.
Orchard TJ; Forrest KY; Ellis D; Becker DJ
Arch Intern Med; 1997 Sep; 157(16):1851-6. PubMed ID: 9290544
[TBL] [Abstract][Full Text] [Related]
17. High Prevalence and Incidence of Diabetic Peripheral Neuropathy in Children and Adolescents With Type 1 Diabetes Mellitus: Results From a Five-Year Prospective Cohort Study.
Walter-Höliner I; Barbarini DS; Lütschg J; Blassnig-Ezeh A; Zanier U; Saely CH; Simma B
Pediatr Neurol; 2018 Mar; 80():51-60. PubMed ID: 29429781
[TBL] [Abstract][Full Text] [Related]
18. Dupuytren's disease in type 1 diabetic patients: a five-year prospective study.
Arkkila PE; Kantola IM; Viikari JS; Rönnemaa T; Vähätalo MA
Clin Exp Rheumatol; 1996; 14(1):59-65. PubMed ID: 8697659
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with avoidance of severe complications after 25 yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I.
Orchard TJ; Dorman JS; Maser RE; Becker DJ; Ellis D; LaPorte RE; Kuller LH; Wolfson SK; Drash AL
Diabetes Care; 1990 Jul; 13(7):741-7. PubMed ID: 2387194
[TBL] [Abstract][Full Text] [Related]
20. Diabetic neuropathy and axon reflex-mediated neurogenic vasodilatation in type 1 diabetes.
Nabavi Nouri M; Ahmed A; Bril V; Orszag A; Ng E; Nwe P; Perkins BA
PLoS One; 2012; 7(4):e34807. PubMed ID: 22529938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
